Folic acid
This article was originally published in The Tan Sheet
Executive Summary
Small increments in nutrient intake have dose-dependent effect on homocysteine reduction, Australian researchers report at American College of Cardiology Annual Scientific Session in Orlando, Fla. March 18-21. Bruce Neal, et al., Institute for International Health, Sydney, studied effects of .2 mg and 2 mg doses of folic acid on plasma homocysteine in a double-blind, placebo-controlled, randomized trial of 723 individuals with history of MI or unstable angina. "Compared to placebo, 2 mg folic acid reduced homocysteine by 1.7 mmol/L and .2 mg reduced homocysteine by 1.2 mmol/L," Neal et al. report, noting effects of both doses "were significantly greater among those with higher homocysteine levels or lower red blood cell folate levels at entry"
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning